JP Morgan and HSBC have filed principal-protected notes with lengthy terms with the SEC, while UBS has registered three five-year autocallables linked to ETFs
Both JP Morgan and Goldman Sachs filed three new products with the US Securities and Exchange Commission on March 21, offering a selection of autocallable, straddle, reverse convertible and leverage...
UBS and Credit Suisse have both filed products based on the performance of Apple shares with the SEC. Half of the latest products registered with the regulator are leveraged return notes
This panel will discuss ways to allocate resources and minimize potential exposure with a set of analytical tools to assess, simulate and quantify operational risk capital to improve business efficiency and performance across the enterprise.
More Analysis articles
The Canadian bank has registered a further three reverse convertibles with the US Securities and Exchange Commission, while JP Morgan and Citi filed straddle products linked to the performance of ETFs
Thirty-five new structured products were listed with the US SEC yesterday, led by a glut of supply from Bank of Montreal
Supply in the US public market remains healthy, with a further 21 products listed with the SEC on March 14. The structures on offer were varied, as was the spread of issuers
Thirty-one structured products were registered with the US Securities and Exchange Commission on March 9, with UBS providing nine autocallables and reverse convertibles
Fifty-two structured products were registered with the US Securities and Exchange Commission on March 7, maintaining the boost in issuance that began the previous day
Rethinking banking supervision
Reverse convertibles continue to dominate structured products registered with the US Securities and Exchange Commission, while ETF underlyings provide the most excitement for those eager to diversify
Barclays Bank has filed two structured products with the US Securities and Exchange Commission based on State Street industrial and technology exchange-traded funds
In response to industry fears of a collateral crunch, regulators have revised the proposed rules on margining for uncleared over-the-counter (OTC) derivatives.You can find out more by downloading this white paper here.